RobinStephanieGolandMD

Diabetes, Lipid Metabolism

J. Merrill Eastman Professor of Diabetes in Medicine and Pediatrics, Columbia P&S

Overview of Dr. Goland

Dr. Robin Goland is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 37 years. Dr. Goland accepts several types of health insurance, listed below. She is one of 142 doctors at New York-Presbyterian Hospital and one of 58 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Endocrinology. She has more than 100 publications and over 500 citings.

Office
1150 Saint Nicholas Ave
2ND FL
New York, NY 10032
Book by Phone+1(828) 351-7127

Fax+1 212-851-5493

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1986
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1980 - 1984
Columbia University Vagelos College of Physicians and SurgeonsClass of 1980

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2002-2014
New York Magazine: Top Doctors Castle Connolly, 2012, 2014
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
Completed
Phase 3
TODAY Genetics Study Start of enrollment: 2008 Aug 01
Completed
PET Scan Imaging of Beta Cell Mass Start of enrollment: 2006 Sep 01
Completed
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Start of enrollment: 2010 Aug 01
Completed
Phase 2
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
Withdrawn
Phase 2
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes Start of enrollment: 2015 Aug 01
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial.
Elizabeth R Seaquist, Lawrence S Phillips, Alokananda Ghosh, Chelsea Baker, Richard M Bergenstal
Plos One. 2024-01-01
19 citations
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman
Diabetes Care. 2023-05-01
36 citations
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
, Steven J Russell, Roy W Beck, Edward R Damiano, Firas H El-Khatib
The New England Journal of Medicine. 2022-09-29

Journal Articles

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults with Type 1 Diabetes
Robin Goland, David Liljenquist, Ruth S Weinstock, JAMA
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes
Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA

Lectures

CGMS Improves Glucose Control in a Heterogenous Outpatient Population with T1D
New York, NY - 6/15/2014

Authored Content

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults with Type 1 DiabetesJune 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020

Press Mentions

New Initiative Explores Obesity-Brain ConnectionApril 5th, 2017
American Lifespan Declines as Obesity and Opioid Epidemic Takes Its TollDecember 20th, 2016
Obesity-Linked Diabetes in Children Resists TreatmentApril 29th, 2012
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment